Pharmacia Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221
Patient Information Leaflet last updated on the eMC: 06/11/2009
PIL Depo-Medrone with Lidocaine

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change due to user-testing of patient information
Updated on 15/05/2008 and displayed until 06/11/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 14/04/2008 and displayed until 15/05/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 12/09/2007 and displayed until 14/04/2008
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 07/03/2007 and displayed until 12/09/2007
Reasons for adding or updating:
  • Change from BAN to rINN
Updated on 16/02/2007 and displayed until 07/03/2007
Reasons for adding or updating:
  • Change from BAN to rINN
Updated on 14/05/2002 and displayed until 16/02/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 31/10/2000 and displayed until 14/05/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   lidocaine hydrochloride
   methylprednisolone acetate


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk